Tumor Infiltrating Lymphocytes (TILs): Old news or the next big thing in cell therapy?
Health Tech World,
After decades in the research space, TILs are ready to shine Cell therapies have revolutionised the precision oncology space…
After decades in the research space, TILs are ready to shine Cell therapies have revolutionised the precision oncology space…
January 29, 2022 2 min read Source/Disclosures Published by: Disclosures: NCI and Iovance Biotherapeutics funded this study.
The role of adoptive cell therapy with tumor-infiltrating lymphocytes for patients with melanoma has undergone scrutiny as…
Iovance Chief Medical Officer Dr. Friedrich Graf Finckenstein (Iovance) Adoptive cell transfer of tumor-infiltrating…